DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Satoh N, Ogawa Y, Usui T, Tagami T, Kono S, Uesugi H, Sugiyama H, Sugawara A, Yamada K, Shimatsu A, Kuzuya H, Nakao K.
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect.
Diabetes Care 2003; 26: 2493-2499
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.